These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15980617)

  • 1. Magnetic resonance imaging of amyloid plaques in transgenic mice.
    Wadghiri YZ; Sigurdsson EM; Wisniewski T; Turnbull DH
    Methods Mol Biol; 2005; 299():365-79. PubMed ID: 15980617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo magnetic resonance imaging of amyloid-β plaques in mice.
    Wadghiri YZ; Hoang DM; Wisniewski T; Sigurdsson EM
    Methods Mol Biol; 2012; 849():435-51. PubMed ID: 22528108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
    Poduslo JF; Wengenack TM; Curran GL; Wisniewski T; Sigurdsson EM; Macura SI; Borowski BJ; Jack CR
    Neurobiol Dis; 2002 Nov; 11(2):315-29. PubMed ID: 12505424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and chemical synthesis of a magnetic resonance contrast agent with enhanced in vitro binding, high blood-brain barrier permeability, and in vivo targeting to Alzheimer's disease amyloid plaques.
    Poduslo JF; Curran GL; Peterson JA; McCormick DJ; Fauq AH; Khan MA; Wengenack TM
    Biochemistry; 2004 May; 43(20):6064-75. PubMed ID: 15147190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-toxic ligand for voxel-based MRI analysis of plaques in AD transgenic mice.
    Sigurdsson EM; Wadghiri YZ; Mosconi L; Blind JA; Knudsen E; Asuni A; Scholtzova H; Tsui WH; Li Y; Sadowski M; Turnbull DH; de Leon MJ; Wisniewski T
    Neurobiol Aging; 2008 Jun; 29(6):836-47. PubMed ID: 17291630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive staining: a novel ex vivo MRI protocol to detect amyloid deposits in mouse models of Alzheimer's disease.
    Dhenain M; Delatour B; Walczak C; Volk A
    Magn Reson Med; 2006 Mar; 55(3):687-93. PubMed ID: 16470593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.
    Jack CR; Garwood M; Wengenack TM; Borowski B; Curran GL; Lin J; Adriany G; Gröhn OH; Grimm R; Poduslo JF
    Magn Reson Med; 2004 Dec; 52(6):1263-71. PubMed ID: 15562496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aptamer-based magnetic resonance imaging contrast agent for detecting oligomeric amyloid-β in the brain of an Alzheimer's disease mouse model.
    Kim ST; Kim HG; Kim YM; Han HS; Cho JH; Lim SC; Lee T; Jahng GH
    NMR Biomed; 2023 Mar; 36(3):e4862. PubMed ID: 36308279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood-brain barrier opening.
    Santin MD; Debeir T; Bridal SL; Rooney T; Dhenain M
    Neuroimage; 2013 Oct; 79():288-94. PubMed ID: 23660031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gd-nanoparticles functionalization with specific peptides for ß-amyloid plaques targeting.
    Plissonneau M; Pansieri J; Heinrich-Balard L; Morfin JF; Stransky-Heilkron N; Rivory P; Mowat P; Dumoulin M; Cohen R; Allémann É; Tόth É; Saraiva MJ; Louis C; Tillement O; Forge V; Lux F; Marquette C
    J Nanobiotechnology; 2016 Jul; 14(1):60. PubMed ID: 27455834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR microscopy of amyloid plaques in five mouse models of amyloidosis and in human Alzheimer's disease brains.
    Dudeffant C; Vandesquille M; Herbert K; Garin CM; Alves S; Blanchard V; Comoy EE; Petit F; Dhenain M
    Sci Rep; 2017 Jul; 7(1):4955. PubMed ID: 28694463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Metal-Free Method for Producing MRI Contrast at Amyloid-β.
    Hilt S; Tang T; Walton JH; Budamagunta M; Maezawa I; Kálai T; Hideg K; Singh V; Wulff H; Gong Q; Jin LW; Louie A; Voss JC
    J Alzheimers Dis; 2017; 55(4):1667-1681. PubMed ID: 27911291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
    Wadghiri YZ; Sigurdsson EM; Sadowski M; Elliott JI; Li Y; Scholtzova H; Tang CY; Aguinaldo G; Pappolla M; Duff K; Wisniewski T; Turnbull DH
    Magn Reson Med; 2003 Aug; 50(2):293-302. PubMed ID: 12876705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents.
    Lee SP; Falangola MF; Nixon RA; Duff K; Helpern JA
    Magn Reson Med; 2004 Sep; 52(3):538-44. PubMed ID: 15334572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting amyloid-β plaques in Alzheimer's disease.
    Baltes C; Princz-Kranz F; Rudin M; Mueggler T
    Methods Mol Biol; 2011; 711():511-33. PubMed ID: 21279620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
    Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.